50 Best Nausea And Vomiting Ad Images in 2020 - BigSpy

SYNDROS | The First & Only FDA-Approved Liquid Tetrahydrocannabinol (THC)
SYNDROS is a prescription medication for breakthrough chemotherapy-induced nausea and vomiting. Ask your doctor about Syndros today. Chemotherapy still making you nauseated? Don’t let CINV knock you down if treatment failed. Ask your doctor about SYNDROS.
AMBOSS: medical knowledge platform for doctors and students
News Break: Local News & Breaking News
Meridian Clinical Research • Site Network • Find a Paid Clinical Trial
CNA - Breaking news, latest Singapore, Asia and world news
TUKYSA™ (tucatinib) tablets | HER2+ MBC Treatment
See TUKYSA Important Facts here: https://bit.ly/2VJEUKk, and Important Safety Information below. What are the possible side effects of TUKYSA? TUKYSA may cause serious side effects, including: • Diarrhea (watery, loose, or frequent stools) is common and can sometimes be severe. Tell your healthcare provider if you have a change in your bowel movements or severe diarrhea. Severe diarrhea can cause a loss of too much body fluid (dehydration), low blood pressure, kidney problems, and death. Your healthcare provider may prescribe medicines to treat your diarrhea during treatment with TUKYSA. • Liver Problems, including severe cases. Your healthcare provider will test your blood to check your liver function before starting and every 3 weeks during treatment with TUKYSA, or as needed. Tell your healthcare provider right away if you have any signs and symptoms of liver problems including itching, yellowing of the skin or eyes, dark or brown urine (tea-colored), pain or discomfort in the right upper stomach area (abdomen), feeling very tired, decreased appetite, or bleeding or bruising more easily than normal. The most common side effects of TUKYSA: - diarrhea - rash, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet - nausea - tiredness - increased liver function blood tests - vomiting - mouth sores (stomatitis) - decreased appetite - stomach-area (abdomen) pain - headache - a low number of red blood cells (anemia) - rash Your healthcare provider may change your dose of TUKYSA, temporarily stop, or permanently stop treatment with TUKYSA if you have certain side effects. TUKYSA may cause fertility problems in males and females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility. These are not all the possible side effects of TUKYSA. Discuss side effects with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA
TUKYSA™ (tucatinib) tablets | HER2+ MBC Treatment
See TUKYSA Important Facts here: https://bit.ly/2VJEUKk, and Important Safety Information below. What are the possible side effects of TUKYSA? TUKYSA may cause serious side effects, including: • Diarrhea (watery, loose, or frequent stools) is common and can sometimes be severe. Tell your healthcare provider if you have a change in your bowel movements or severe diarrhea. Severe diarrhea can cause a loss of too much body fluid (dehydration), low blood pressure, kidney problems, and death. Your healthcare provider may prescribe medicines to treat your diarrhea during treatment with TUKYSA. • Liver Problems, including severe cases. Your healthcare provider will test your blood to check your liver function before starting and every 3 weeks during treatment with TUKYSA, or as needed. Tell your healthcare provider right away if you have any signs and symptoms of liver problems including itching, yellowing of the skin or eyes, dark or brown urine (tea-colored), pain or discomfort in the right upper stomach area (abdomen), feeling very tired, decreased appetite, or bleeding or bruising more easily than normal. The most common side effects of TUKYSA: - diarrhea - rash, redness, pain, swelling, or blisters on the palms of your hands or soles of your feet - nausea - tiredness - increased liver function blood tests - vomiting - mouth sores (stomatitis) - decreased appetite - stomach-area (abdomen) pain - headache - a low number of red blood cells (anemia) - rash Your healthcare provider may change your dose of TUKYSA, temporarily stop, or permanently stop treatment with TUKYSA if you have certain side effects. TUKYSA may cause fertility problems in males and females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility. These are not all the possible side effects of TUKYSA. Discuss side effects with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA
AMBOSS: medical knowledge platform for doctors and students
A 36-year-old man comes to the emergency department 4 hours after a bike accident for severe pain and swelling in his right leg. He has not had a headache, nausea, vomiting, abdominal pain, or blood in his urine. He has a history of gastroesophageal reflux disease and allergic rhinitis. He has smoked one pack of cigarettes daily for 17 years and drinks an average of one alcoholic beverage daily. His medications include levocetirizine and pantoprazole. He is in moderate distress. His temperature is 37°C (98.6°F), pulse is 112/min, and blood pressure is 140/80 mm Hg. Examination shows multiple bruises over both lower extremities and the face. There is swelling surrounding a 2 cm laceration 13 cm below the right knee. The lower two-thirds of the tibia is tender to palpation and the skin is pale and cool to the touch. The anterior tibial, posterior tibial, and dorsalis pedis pulses are weak. Capillary refill time of the right big toe is 4 seconds. Dorsiflexion of his right foot causes severe pain in his calf. Cardiopulmonary examination is normal. An x-ray is ordered, which is shown below. Which of the following is the most appropriate next step in management? A - Low molecular weight heparin B - Open reduction and internal fixation C - Above knee cast D - Fasciotomy E - Intravenous clindamycin F - IVC filter placement
Eat for Health with Healthy Eating Doctor · Healthy Eating Doctor
Eat for Health with Healthy Eating Doctor · Healthy Eating Doctor
Eat for Health with Healthy Eating Doctor · Healthy Eating Doctor
Eat for Health with Healthy Eating Doctor · Healthy Eating Doctor
Mason Connolly, D.C.
News Break: Local News & Breaking News
everymum - The Parenting Community Connecting & Celebrating Every Mum - everymum
GSKPro for Healthcare Professionals
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2020 GSK or licensor. FVUBNNR190031 January 2020 Produced in USA.
News Break: Local News & Breaking News
wisp
Immune Thrombocytopenia (ITP) Treatment | Nplate® (romiplostim)
Immune Thrombocytopenia (ITP) Treatment | Nplate® (romiplostim)
Gut Alive
Are we destroying our gut with acid reducers, antacids, PPIs, and H2 blockers? We’ve been told to reach out for those meds whenever the acid regurgitates back to our throat or when the burning sensation gets too painful. But what most people don’t realize is that stomach acid is an important component in assisting our stomach to digest food. Without sufficient stomach acid, the food we consume sits in our gut, undigested for hours, making us feel bloated. The thing is stomach acids are important for our body because we need an acidic environment to absorb essential nutrients, vitamins, and minerals into our gut. Instead of laying blame on our stomach acid, we should address the root cause of reflux and indigestion. Gut experts are now recommending that instead of stopping the stomach acid, we should focus on healing the lining of our gut. The lining of our gut is like our skin. It covers and protects everything inside your body. Similarly, the lining of our gut protects our organs from the harmful bacteria and virus in the food we eat. It’s when our gut lining is broken that we start to experience the burning sensation or pain whenever food or liquid regurgitates up. That is why healing our gut lining is extremely important. The good news is there are 4 super gut-healing ingredients that can help heal and support the lining of our gut. Ingredient #1 : Zinc-Carnosine from PepZin GI Zinc-Carnosine is a breakthrough patented nutrient discovered by the Japanese scientists, where they found that by combining Zinc with L-Carnosine, zinc is able to ease reflux symptoms by healing our gut lining. Ingredients #2 & #3: Ginger Root and Deglycyrrhizinated Licorice Root (DGL) Both of these ingredients stimulate mucin production to protect the stomach lining. Mucin is like a band-aid that helps heal the damaged area of our esophagus and gut so when the acid comes into contact with the wall of our gut, it will not hurt that much. Ingredient #4: Artichoke Leaf stimulates the production of bile, which is needed for the efficient digestion of fats, and reduces symptoms such as nausea, vomiting, flatulence, and stomach pain in people with indigestion. The good news is that we've incorporated these gut superfoods into our flagship gut supplement & everyone is getting amazing results. ==== The New Gut Health Supplement Everyone is Talking About === Gut Alive is our best selling gut-healing formula with the following ingredients - Zinc-Carnosine®, deglycerized licorice root, ginger and artichoke leaf extract, with scientifically-proven dosage to help support your esophagus health. - Features Zinc-Carnosine®, a clinically researched gut lining mineral that supports the repair of the gut mucosal barrier. - Eases bloating, stomach discomfort, and burning sensation in our chest. - Supports a healthy immune system by ensuring our gut is not compromised. Our ingredients are all natural and we do not include any synthetic vitamins, binders or fillers because we put your health as our #1 priority. This is an all-in-one formula that provides all the necessary nutrients to achieve the optimum health that we want for our digestive system. By combining all these ingredients into our breakthrough gut supplement, Gut Alive, the results surpassed our customers’ expectations. *** 30-day money-back guarantee, vegetarian-friendly, made in an FDA registered, GMP certified facility right here in the US with global ingredients*** Read reviews, see results, and find out if our ingredients are the right fit for you here - => https://gutalive.com/gut-alive-written/letter/?aid=85&campaign-protectstomach&pl=newwritten
News Break: Local News & Breaking News
Home
Emeterm is a quick drug-free nausea relief band that relieves retching, nausea, and vomiting caused by morning sickness (during pregnancy), motion sickness, and medically induced nausea (Chemotherapy).
AMBOSS: medical knowledge platform for doctors and students
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190033 December 2019 Produced in USA.
COPD Treatment | TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol)
IMPORTANT SAFETY INFORMATION • Do not use TRELEGY to relieve sudden breathing problems. Always have a rescue inhaler with you to treat sudden symptoms. • Do not use TRELEGY if you have a severe allergy to milk proteins or are allergic to any of the ingredients in TRELEGY. Ask your healthcare provider if you are not sure. • Do not use TRELEGY more often than prescribed. • Do not take TRELEGY with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need your rescue inhaler more often than usual or it does not work as well to relieve your symptoms. • TRELEGY can cause serious side effects, including: − fungal infection in your mouth or throat (thrush). Rinse your mouth with water without swallowing after using TRELEGY to help reduce your chance of getting thrush. − pneumonia. People with COPD have a higher chance of getting pneumonia. TRELEGY may increase the chance of getting pneumonia. Call your healthcare provider if you notice any of the following symptoms: change in amount or color of mucus; fever; chills; increased cough; increased breathing problems. − weakened immune system and increased chance of getting infections. − reduced adrenal function. This can happen when you stop taking oral corticosteroids and start taking inhaled corticosteroids. − sudden breathing problems immediately after inhaling TRELEGY. If this happens, stop taking TRELEGY and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; hives; swelling of your face, mouth, and tongue; breathing problems. − effects on heart: increased blood pressure; a fast or irregular heartbeat, awareness of heartbeat; chest pain. − effects on nervous system: tremor; nervousness. − bone thinning or weakness (osteoporosis). − eye problems including glaucoma, increased pressure in your eye, cataracts, blurred vision, worsening of narrow-angle glaucoma, or other changes in vision. You should have regular eye exams while using TRELEGY ELLIPTA. Acute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: o eye pain or discomfort o seeing halos or bright colors around lights o nausea or vomiting o red eyes o blurred vision If you have these symptoms, call your healthcare provider right away before taking another dose. − new or worse urinary retention. Symptoms may include: difficult, painful, or frequent urination; urination in a weak stream or drips. If you have these symptoms, stop taking TRELEGY and call your healthcare provider right away. − changes in laboratory blood values, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia). • Common side effects of TRELEGY include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth and throat (rinse your mouth with water without swallowing after use to help prevent this); headache; back pain; joint pain; flu; inflammation of the sinuses; runny nose and sore throat; taste disturbance; constipation; painful and frequent urination (signs of a urinary tract infection); nausea, vomiting, and diarrhea; mouth and/or throat pain; cough; and hoarseness. Please see full Prescribing Information, including Patient Information, for TRELEGY ELLIPTA at https://bit.ly/2Irospw. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about TRELEGY. Sponsored by GSK. For US audiences only. TRELEGY ELLIPTA was developed in collaboration with INNOVIVA. Trademarks are owned by or licensed to the GSK group of companies. ©2019 GSK or licensor. FVUBNNR190028 December 2019 Produced in USA.
Agni
Best Hospital in Hyderabad : Pace Hospitals
#Gallstones form due to gallbladder contractility issues and dysfunction. ✳ What are the symptoms of Gallstones? Gallstones may become lodged in the neck of the gallbladder or in the bile ducts. When the gallbladder is plugged in this way, bile can’t exit. This may lead to the #gallbladder becoming inflamed or distended and this can lead to pain in the upper right abdomen. You may also experience: ✅ Severe stomach pain ✅ Nausea and vomiting ✅ Jaundice, a yellowish tint to your skin or eyes ✅ Dark urine ✅ Clay-colored stools ✅ Burping and indigestion / diarrhea ✳ Treatment of Gallstones: Gallstones can be diagnosed by physical exam and other tests include: Blood Tests, Ultrasound, CT Scan, #MRCP, ERCP (Endoscopic retrograde cholangiopancreatography), #Endoscopic ultrasound ✅ Laparoscopic #Cholecystectomy (The surgery to remove the gallbladder): A cholecystectomy is most commonly performed surgery to treat gallstones ✅ #ERCP (Endoscopic retrograde cholangiopancreatography): a procedure that can be used to remove gallstones from the bile duct. ✅ #EUS-guided gallbladder drainage: a procedure for patients who all are not eligible for surgical intervention. For Gallstones treatment request an appointment: https://www.pacehospital.com/gallstones-treatment #DrRavulaPhaniKrishna #Gastroenterologist Dept of #Gastrointestinal, #HPB and #Minimally Invasive Surgery #PaceHospitals T:040 48486868 Hitech City and Madinaguda
News Break: Local News & Breaking News
Home Page | IBRANCE® (palbociclib) | Safety Info
Please see full Prescribing Information for prescription IBRANCE® capsules or tablets here: bit.ly/30nsqZO INDICATIONS IBRANCE 125 mg capsules and tablets are a prescription medicine used in adults to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that has spread to other parts of the body (metastatic) in combination with an aromatase inhibitor as the first hormonal based therapy in postmenopausal women or in men, or fulvestrant in people with disease progression following hormonal therapy. IMPORTANT SAFETY INFORMATION IBRANCE may cause serious side effects, including: Low white blood cell counts (neutropenia). Low white blood cell counts are very common when taking IBRANCE and may cause serious infections that can lead to death. Your doctor should check your white blood cell counts before and during treatment. If you develop low white blood cell counts during treatment with IBRANCE, your doctor may stop your treatment, decrease your dose, or may tell you to wait to begin your treatment cycle. Tell your doctor right away if you have signs and symptoms of low white blood cell counts or infections such as fever and chills. Lung problems (pneumonitis). IBRANCE may cause severe inflammation of the lungs during treatment that can lead to death. Tell your doctor right away if you have any new or worsening symptoms, including chest pain, cough with or without mucus, and trouble breathing or shortness of breath. Your doctor may interrupt or stop treatment with IBRANCE completely if your symptoms are severe. Before you take IBRANCE, tell your doctor about all of your medical conditions, including if you: • have fever, chills, or any other signs or symptoms of infection. • have liver or kidney problems. • are pregnant or plan to become pregnant; IBRANCE can harm your unborn baby. o Females who are able to become pregnant should use effective birth control during treatment and for at least 3 weeks after the last dose of IBRANCE. Your doctor may ask you to take a pregnancy test before you start treatment with IBRANCE. o Males with female partners who can become pregnant should use effective birth control during treatment with IBRANCE for at least 3 months after the last dose of IBRANCE. • are breastfeeding or plan to breastfeed. It is not known if IBRANCE passes into your breast milk. Do not breastfeed during treatment with IBRANCE and for 3 weeks after the last dose. The most common side effects of IBRANCE include: • Low red blood cell counts and low platelet counts. Call your doctor right away if you develop any of these symptoms during treatment: o dizziness o shortness of breath o weakness o bleeding or bruising more easily o nosebleeds • infections, tiredness, nausea, sore mouth, abnormalities in liver blood tests, diarrhea, hair thinning or hair loss, vomiting, rash, and loss of appetite. IBRANCE may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider about family planning options before starting IBRANCE if this is a concern for you. These are not all of the possible side effects of IBRANCE. For more information, ask your doctor. Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. IBRANCE and other medicines may affect each other, causing side effects. Do not drink grapefruit juice or eat grapefruit products while taking IBRANCE as they may increase the amount of IBRANCE in your blood. Tell your doctor if you start a new medicine. Take IBRANCE exactly as your doctor tells you. If you take too much IBRANCE, call your doctor right away or go to the nearest hospital emergency room. Ambassadors were asked to share their personal stories about IBRANCE. All content was accurate at the time of publication and may have since changed. © 2020 Pfizer Inc. All rights reserved. Rx only. June 2020 PP-IBR-USA-3817
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190014 November 2019 Produced in USA.
COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Prescribing Info: http://bit.ly/2zUiw6Q. Prescription ANORO is used long term to treat COPD, including chronic bronchitis, emphysema, or both. ANORO is not used to relieve sudden symptoms of COPD, won't replace a rescue inhaler, and is not for asthma. IMPORTANT SAFETY INFORMATION • Do not use ANORO to treat sudden symptoms of chronic obstructive pulmonary disease (COPD). Always have a rescue inhaler with you to treat sudden symptoms. • Do not use ANORO if you have a severe allergy to milk proteins or are allergic to any of the ingredients in ANORO. Ask your healthcare provider if you are not sure. • Do not use ANORO if you have asthma. • Do not use ANORO more often than prescribed. • Do not take ANORO with other medicines that contain a long-acting beta2-adrenergic agonist (LABA) or an anticholinergic for any reason. Tell your healthcare provider about all your medical conditions and about all the medicines you take. • Call your healthcare provider or get medical care right away if your breathing problems get worse, if you need to use your rescue inhaler more often than usual, or if your rescue inhaler does not work as well to relieve your symptoms. • ANORO can cause serious side effects, including: − COPD symptoms that get worse over time. If this happens, do not increase your dose of ANORO; instead, call your healthcare provider. − symptoms of using too much of a LABA medicine, including: chest pain; increased blood pressure; fast or irregular heartbeat; headache; tremor; nervousness. − sudden breathing problems immediately after inhaling your medicine. If you experience this, stop using ANORO and call your healthcare provider right away. − serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms: rash; swelling of your face, mouth, and tongue; hives; breathing problems. − effects on heart: increased blood pressure; chest pain; a fast or irregular heartbeat, awareness of heartbeat. − effects on nervous system: tremor; nervousness. − new or worsened eye problems, including acute narrow-angle glaucoma that can cause permanent loss of vision if not treated. Symptoms may include: eye pain or discomfort; nausea or vomiting; blurred vision; seeing halos or bright colors around lights; red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose. − urinary retention. People who take ANORO may develop new or worse urinary retention. Symptoms may include: difficulty urinating; painful urination; urinating frequently; urination in a weak stream or drips. If you have these symptoms, stop taking ANORO and call your healthcare provider right away before taking another dose. − changes in laboratory blood levels, including high levels of blood sugar and low levels of potassium. • Common side effects of ANORO include: sore throat; sinus infection; lower respiratory infection; common cold symptoms; constipation; diarrhea; pain in your arms or legs; muscle spasms; neck pain; chest pain. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Talk to your doctor about ANORO. Please see full Prescribing Information, including Patient Information, for ANORO at http://bit.ly/2zUiw6Q. Visit https://www.anoro.com or call 1-844-44-ANORO to learn more. Sponsored by GSK. For US audiences only. ANORO ELLIPTA was developed in collaboration with INNOVIVA Trademarks are owned by or licensed by GSK. ©2019 GSK or licensor. UCVOGM190016 November 2019 Produced in USA.
Official Homepage for ANNOVERA® Contraceptive (segesterone acetate and ethinyl estradiol vaginal system) Consumer Site | TherapeuticsMD
IMPORTANT RISK INFORMATION • Do not use ANNOVERA if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious heart and blood vessel (cardiovascular) side effects from hormonal birth control methods, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke. • ANNOVERA does not protect against HIV infection (AIDS) and other sexually transmitted infections. • The use of a combination hormonal contraceptive (CHC), like ANNOVERA, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. Do not use ANNOVERA if you have a history of these conditions, have reduced blood flow to your brain (cerebrovascular disease) or reduced blood flow or blockage in any of the arteries that supply blood to your heart (cardiovascular disease), or any condition that makes your blood more likely to clot. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for 4 weeks or more. • ANNOVERA is also not for women with high blood pressure that medicine can’t control or high blood pressure with blood vessel damage; diabetes and over 35 years old, diabetes with high blood pressure or kidney, eye, nerve, or blood vessel damage, diabetes for longer than 20 years; certain kinds of severe migraine headaches; liver disease or liver tumors; breast cancer or any cancer that is sensitive to the female hormones estrogen or progesterone; unexplained vaginal bleeding; are allergic to segesterone acetate, ethinyl estradiol or any other ingredients in ANNOVERA; or take any Hepatitis C drug combination containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of the liver enzyme “alanine aminotransferase” (ALT) in the blood. • ANNOVERA can cause serious side effects, including: blood clots; toxic shock syndrome (TSS); liver problems, including liver tumors; high blood pressure; gallbladder problems; changes in the sugar and fat (cholesterol and triglycerides) levels in your blood; headache; irregular or unusual vaginal bleeding and spotting between your menstrual periods; depression; possible cancer in your cervix; swelling of your skin especially around your mouth, eyes, and in your throat (angioedema); dark patches of skin on your forehead, cheeks, upper lip, and chin (chloasma). Call your healthcare provider or get emergency medical care right away if any of these serious side effects occur. • The most common side effects reported in at least 5% of women who received ANNOVERA were: headache/migraine, nausea/vomiting, vaginal yeast infection (candidiasis), lower/upper abdominal pain, painful periods, vaginal discharge, urinary tract infection, breast pain/tenderness, irregular vaginal bleeding, diarrhea, and genital itching. USE ANNOVERA is a ring-shaped vaginal system with hormones used by females to prevent pregnancy. ANNOVERA has not been adequately studied in females with a body mass index >29 kg/m². The risk information provided here is not complete. To learn more, review the ANNOVERA Patient Information and talk with your healthcare provider or pharmacist. The FDA-approved product labeling, including Patient Information, can be found at ANNOVERA.com. You may report side effects to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088. You may also report side effects to TherapeuticsMD at 1-888-228-0150. ANNOVERA is a registered trademark licensed to TherapeuticsMD, Inc. © 2020 TherapeuticsMD, Inc. All rights reserved.
GiveIndia - India’s largest & most trusted Donation Platform
GiveIndia - India’s largest & most trusted Donation Platform
GiveIndia - India’s largest & most trusted Donation Platform
Urology Austin - Female Urology - Male Urology - General Urology
Official Homepage for ANNOVERA® Contraceptive (segesterone acetate and ethinyl estradiol vaginal system) Consumer Site | TherapeuticsMD
IMPORTANT RISK INFORMATION • Do not use ANNOVERA if you smoke cigarettes and are over 35 years old. Smoking increases your risk of serious heart and blood vessel (cardiovascular) side effects from hormonal birth control methods, including death from heart attack, blood clots, or stroke. This risk increases with age and the number of cigarettes you smoke. • ANNOVERA does not protect against HIV infection (AIDS) and other sexually transmitted infections. • The use of a combination hormonal contraceptive (CHC), like ANNOVERA, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. Do not use ANNOVERA if you have a history of these conditions, have reduced blood flow to your brain (cerebrovascular disease) or reduced blood flow or blockage in any of the arteries that supply blood to your heart (cardiovascular disease), or any condition that makes your blood more likely to clot. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for 4 weeks or more. • ANNOVERA is also not for women with high blood pressure that medicine can’t control or high blood pressure with blood vessel damage; diabetes and over 35 years old, diabetes with high blood pressure or kidney, eye, nerve, or blood vessel damage, diabetes for longer than 20 years; certain kinds of severe migraine headaches; liver disease or liver tumors; breast cancer or any cancer that is sensitive to the female hormones estrogen or progesterone; unexplained vaginal bleeding; are allergic to segesterone acetate, ethinyl estradiol or any other ingredients in ANNOVERA; or take any Hepatitis C drug combination containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, as this may increase levels of the liver enzyme “alanine aminotransferase” (ALT) in the blood. • ANNOVERA can cause serious side effects, including: blood clots; toxic shock syndrome (TSS); liver problems, including liver tumors; high blood pressure; gallbladder problems; changes in the sugar and fat (cholesterol and triglycerides) levels in your blood; headache; irregular or unusual vaginal bleeding and spotting between your menstrual periods; depression; possible cancer in your cervix; swelling of your skin especially around your mouth, eyes, and in your throat (angioedema); dark patches of skin on your forehead, cheeks, upper lip, and chin (chloasma). Call your healthcare provider or get emergency medical care right away if any of these serious side effects occur. • The most common side effects reported in at least 5% of women who received ANNOVERA were: headache/migraine, nausea/vomiting, vaginal yeast infection (candidiasis), lower/upper abdominal pain, painful periods, vaginal discharge, urinary tract infection, breast pain/tenderness, irregular vaginal bleeding, diarrhea, and genital itching. USE ANNOVERA is a ring-shaped vaginal system with hormones used by females to prevent pregnancy. ANNOVERA has not been adequately studied in females with a body mass index >29 kg/m². The risk information provided here is not complete. To learn more, review the ANNOVERA Patient Information and talk with your healthcare provider or pharmacist. The FDA-approved product labeling, including Patient Information, can be found at ANNOVERA.com. You may report side effects to the FDA at www.fda.gov/medwatch or by calling 1-800-FDA-1088. You may also report side effects to TherapeuticsMD at 1-888-228-0150. ANNOVERA is a registered trademark licensed to TherapeuticsMD, Inc. © 2020 TherapeuticsMD, Inc. All rights reserved.
Migraine Buddy - The Migraine and Headache tracker
Nº1 Migraine and Headache tracking app - Take control and join 2.3Million users. Designed with Neurologists. Migraine is a neurological condition, which affects about 15% of the population. On top of the extreme throbbing pain, migraines can be accompanied by symptoms such as nausea, extreme sensitivity to light/sound or even vomiting in some more severe cases. Recording all migraine and headaches attacks with Migraine Buddy helps keep track of the reliefs and their effectiveness which will be useful information for you and your doctor when seeking for diagnosis or for suitable treatment!
News Break: Local News & Breaking News
News Break: Local News & Breaking News
MyMoringa "Organic"
MyMoringa "Organic"
MyMoringa "Organic"
MyMoringa "Organic"
MyMoringa "Organic"
MyMoringa "Organic"
News Break: Local News & Breaking News
News Break: Local News & Breaking News
Reliefband®
Reliefband is the drug-free, FDA-cleared device that treats nausea and vomiting—just by wearing it on your wrist!